OX40 Rezeptor bindende Agenzien

Patent europeic · EP1492813 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1492813
Numer da la dumonda
EP03730172
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
02-04-2003
Publitgà
05-01-2005
Concedì
09-05-2012
Stritgà
30-04-2013
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/52 (2006.01)
C07K 14/705 (2006.01)
C12N 15/28 (2006.01)
C12N 5/10 (2006.01)
C12N 15/63 (2006.01)
G01N 33/53 (2006.01)
A61K 38/00 (2006.01)
A61P 31/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
Prioritad
EP 02100334 03.04.2002
Dumonda PCT
PCT/EP2003/050089 02.04.2003
Publicaziun PCT
WO2003/082919 09.10.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-11-2013

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.11.2013

  2. 22-06-2012

    Represchentant inscrit

    Representative
    Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva

    Published in Swissreg on 22.06.2012

  3. 09-05-2012

    Concedì

    Published in Swissreg on 09.05.2012

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.